Seroba Life Sciences

Seroba Life Sciences is a pan-European life sciences venture firm headquartered in Dublin that backs biotech and medtech innovators across the United Kingdom, Ireland, and continental Europe. The firm is recognized as one of the more established life sciences specialists in Ireland, with experience supporting therapeutic and medical device companies through clinical, regulatory, and commercial milestones. Within healthcare, the focus is concentrated in biotech and medical devices and medtech, with disclosed portfolio activity including Coave Therapeutics, a gene therapy company, illustrating an appetite for technically demanding therapeutic platforms. The team values scientific rigor, defensible IP, and credible paths through European and US regulatory frameworks. Seroba typically engages at Series A and Series B, with check sizes generally in the 5M to 25M range. The firm is comfortable leading or co-leading rounds, taking board representation, and participating in subsequent financings as companies progress through clinical and commercial milestones. The capital structure supports concentrated portfolios with hands-on board engagement. Geographic activity is pan-European, with particular strength in Ireland, the United Kingdom, France, Germany, and surrounding markets, and selective transatlantic exposure where companies have material US activity. Founders engaging Seroba should expect technically grounded diligence with attention to scientific differentiation, clinical strategy, and regulatory positioning, paired with post-investment partnership oriented around board-level support, follow-on capital strategy, and introductions to broader European and US life sciences syndicates. The firm tends to favor experienced biotech and medtech management teams with credible scientific founders. Limited public information is available regarding the full current portfolio and individual partner attributions beyond publicly disclosed deals.